deltatrials
Completed NA INTERVENTIONAL 1-arm NCT01739673

Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis

Sponsor: Cxlusa

Conditions Infectious Keratitis
Interventions Ultraviolet-A and riboflavin
Updated 7 times since 2017 Last updated: Sep 24, 2018 Started: Aug 31, 2011 Primary completion: Jul 31, 2014 Completion: Jul 31, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Infectious Keratitis and is currently completed. Cxlusa leads this study, which shows 7 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshotCompleted~Oct 2018 – ~Jan 2021 · 27 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  5. Oct 2018 — Jan 2021 [monthly]

    Completed NA

▶ Show 2 earlier versions

  1. Jun 2018 — Oct 2018 [monthly]

    Completed NA

  2. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Aug 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cxlusa
Data source: Cxlusa

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations